Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 06 1995, 1617-1623, Vol 33, No. 6
TA Felmlee, Q Liu, AC Whelen, D Williams, SS Sommer and DH Persing
Detection of mutations in the rpoB gene of Mycobacterium tuberculosis can
be used as an accurate predictor of rifampin resistance in the majority of
strains tested. Simple but highly accurate screening methods must be
developed for the detection of these mutations. Either DNA sequence
analysis or single-strand conformation polymorphism (SSCP) screening can be
used to detect rpoB mutations, but these techniques either are expensive or
yield results that may prove difficult to interpret when used in a clinical
setting. This report describes the use of dideoxy fingerprinting (ddF) as a
postamplification screening method to identify rifampin-resistant
genotypes. The ddF protocol was performed on the amplified rpoB fragment
with no preparatory steps, thus making ddF practical for laboratories
equipped for polyacrylamide gel electrophoresis. When compared with the
results of SSCP analysis, ddF results were more easily interpreted and
contained more sequence- dependent information that facilitated
differentiation of functionally significant and silent mutations. The ddF
method was used for genotypic determination of rifampin susceptibility of
20 multidrug-resistant strains of M. tuberculosis. The results of this
analysis were concordant with DNA sequence analysis and conventional
clinical laboratory methods.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting
Division of Clinical Microbiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|